Azetidine and cyclobutane derivatives as JAK inhibitors
US8158616B2 · kind B2 · utility
133Cited by
6References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2009 |
| Grant date | Apr 17, 2012 |
| Priority date | — |
| Expiry date | Jun 8, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S362/802
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.